Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05508061Not ApplicableCompleted

Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes

Role: lead

NCT05669547Not ApplicableCompleted

Dual Hormone Closed Loop in Type 1 Diabetes

Role: collaborator

NCT05454709Phase 2Withdrawn

A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System

Role: lead

NCT05543850Not ApplicableCompleted

Portable Artificial Pancreas Applied for Youth and Adolescents

Role: lead

NCT03858062Not ApplicableCompleted

Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format,

Role: collaborator

All 5 trials loaded